首页|上皮性卵巢癌组织中LRRC15、SUN2表达变化及其与患者预后的关系

上皮性卵巢癌组织中LRRC15、SUN2表达变化及其与患者预后的关系

扫码查看
目的 探讨富含亮氨酸重复序列15(LRRC15)、SUN结构域蛋白2(SUN2)在上皮性卵巢癌(EOC)组织中的表达变化及其与患者预后的关系。方法 选取102例EOC患者手术切除癌组织(观察组),以60例因卵巢良性囊肿行手术治疗的正常卵巢组织为对照组。采用免疫组化法检测癌及正常卵巢组织中LRRC15、SUN2表达。通过Spearman秩相关分析评估LRRC15与SUN2表达的相关性,采用Kaplan-Meier生存曲线和Cox回归分析LRRC15、SUN2表达与EOC患者预后的关系。结果 观察组LRRC15阳性率高于对照组,SUN2阳性率低于对照组,差异有统计学意义(P均<0。05)。观察组中LRRC15与SUN2表达呈负相关(r=-0。634,P<0。05)。LRRC15在EOC患者FIGO分期Ⅲ期、淋巴结转移中的阳性率高于FIGO分期Ⅰ~Ⅱ期、无淋巴结转移癌组织,SUN2在EOC患者FIGO分期Ⅲ期、淋巴结转移中的阳性率低于FIGO分期Ⅰ~Ⅱ期、无淋巴结转移癌组织,差异有统计学意义(P均<0。05)。LRRC15阳性组EOC患者3年总生存率低于LRRC15阴性组,SUN2阴性组EOC患者3年总生存率低于SUN2阳性组,差异均有统计学意义(P均<0。05)。FIGO分期Ⅲ期、病理分级Ⅲ级、淋巴结转移、LRRC15阳性是影响EOC患者预后的危险因素,SUN2阳性是保护因素(P均<0。05)。结论 EOC患者癌组织中LRRC15表达升高、SUN2表达降低,LRRC15、SUN2表达与EOC肿瘤进展有关,检测二者水平有助于评估EOC患者预后。
Expression changes of LRRC15 and SUN2 in epithelial ovarian cancer tissues and their relationships with prognosis of patients
Objective To analyze the expression changes of leucine-rich repeat containing 15(LRRC15)and Sad1 and UNC84 domain protein 2(SUN2)in epithelial ovarian cancer(EOC)tissues and to investigate their relationships with the prognosis of patients.Methods Totally 102 cases of cancer tissues resected from patients with EOC were selected as the observation group,and 60 cases of normal ovarian tissues from patients who underwent surgical treatment due to benign ovarian cysts were used as the control group.The expression levels of LRRC15 and SUN2 in the cancer and normal ovarian tissues were detected by immunohistochemistry.The correlation between the expression levels of LRRC15 and SUN2 was evaluated by Spearman rank correlation.The relationships between the expression levels of LRRC15 and SUN2 and the prognosis of patients with EOC were analyzed by Kaplan-Meier curve and Cox regression analysis.Results The positive rate of LRRC15 in the observation group was higher than that in the control group,and the positive rate of SUN2 was lower than that in the control group,with statistically significant differences(both P<0.05).In the observation group,the expres-sion of LRRC15 was negatively correlated with the expression of SUN2(r=-0.634,P<0.05).The positive rate of LR-RC15 in EOC patients with FIGO stage Ⅲ and lymph node metastasis was higher than that in cancer tissues with FIGO stag-es Ⅰ-Ⅱ and without lymph node metastasis,and the positive rate of SUN2 in EOC patients with FIGO stage Ⅲ and lymph node metastasis was lower than that in cancer tissues with FIGO stages Ⅰ-Ⅱ and without lymph node metastasis,with statis-tically significant differences(all P<0.05).The 3-year overall survival rate of EOC patients in the LRRC15 positive group was lower than that in the LRRC15 negative group,and the 3-year overall survival rate of EOC patients in the SUN2 negative group was lower than that in the SUN2 positive group,with statistically significant differences(all P<0.05).FIGO stage Ⅲ,pathological grade Ⅲ,lymph node metastasis,and positive LRRC15 were risk factors for the prognosis of EOC patients,and positive SUN2 was a protective factor.Conclusions The expression level of LRRC15 increases and the expression level of SUN2 decreases in the cancer tissues of EOC patients.The expression levels of LRRC15 and SUN2 are related to the tu-mor progression of EOC.Detection of the levels of the two is helpful for evaluating the prognosis of EOC patients.

ovarian carcinomaleucine-rich repeat containing 15Sad1 and UNC84 domain protein 2prognosis

赵萌、黄丹青、祝愿

展开 >

淄博市妇幼保健院妇科,山东淄博 255000

卵巢癌 富含亮氨酸重复序列15 SUN结构域蛋白2 预后

山东省医药卫生科技发展计划项目

202005010441

2024

山东医药
山东卫生报刊社

山东医药

CSTPCD
影响因子:1.225
ISSN:1002-266X
年,卷(期):2024.64(22)
  • 1